Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
CT conolography has been growing in popularity for several years, largely due to the benefits for patient comfort. New research is now showing advancements and benefits of using machine learning with this method of screening for colon cancer. Look for coverage in the coming days of a study being published later this week.
For more CT colonography coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Pinpointing the correct treatment strategy for patients with acute ischemic stroke can be difficult. But, incorporating MRI with X-ray angiography can make the process easier, leading to improved patient outcomes. Findings published in Radiology recently shows that this combination works well to guide providers in deciding on the best therapy. Keep your eyes open for this story later in the week.
For more coverage acute ischemic stroke, click here.
February is American Heart Month, and state-of-the art, cutting edge cardiovascular imaging is critical to helping providers offer the best heart care possible. This week, Diagnostic Imaging spoke with industry experts about what is on the horizon with cardiovascular imaging. What does the future look like, and what does this mean for both patient and provider? Look for the story later in the week.
For additional coverage on cardiovascular imaging, click here.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.